Historic Data Marks Breakthrough for Pancreatic Cancer
This is a historic data release. A real advance for pancreatic cancer patients, and it shows that our industry goes after the hardest things and can win. #ASCO26 https://t.co/w6F1yAkwK0
Leaders Shouldn't Demand Questions Before the Interview
Had an opportunity to sit down with Commissioner Makary for BiotechTV earlier this year, but only if I provided the questions in advance, which I don’t do. I say it to everyone who asks…if the person needs the questions in...
Catalyst Poised as Florida’s First Multi‑Billion Biotech Exit
Is Catalyst (based in Coral Gables) the first Florida biotech to have a multi billion exit?
Kalshi Offers Odds on FDA Commissioner Makary’s Tenure
Kalshi now has odds on Commissioner Makary’s term at FDA. Very thin liquidity and wide spreads so I wouldn’t put much credence into these numbers currently but still interesting. https://t.co/rMdpTWB5ES
German Lab Prints Tumors to Study Neutrophil Interactions
One of the cooler things I saw during my visit to Germany last week was this tumor printer. The company is using it to test how neutrophils affect the tumor microenvironment. https://t.co/jXzxDpj6nZ
ETF Firms Seek SEC Approval for Prediction Market Funds
Amazed to learn that ETF companies have filed for prediction market ETFs for yes/no events like election results. They would be derivatives tied to platforms like Kalshi. SEC is reviewing and asked for more info today.
Exploring Germany's Emerging Biotech Hubs in Tübingen and Heidelberg
All this week, I'm in Germany checking out the biotech scene in a couple of university towns: Tübingen and Heidelberg. Tune in.
FDA Criticizes Replimune's Melanoma Trial Design
Some observers, including @US_FDA, have criticized @Replimune for the design of the trial that led to the decision not to grant accelerated approval of their melanoma treatment. I asked the company's Chairman about that view. Watch the full interview: https://t.co/XYVmSeodLv https://t.co/OO8eXTZOXh
Ask Your Questions for Upcoming Replimune Chairman Interview
Later today, I'm going over to Replimune to speak with their Chairman about all that's happened. Let me know any questions you'd like me to ask. Scheduled to record at noon and it will be up later in the afternoon.
Duchenne Kids Show Dramatic Improvement After Microdystrophin Treatment
A couple of weeks ago when I visited Solid Bio, they showed me some videos of Duchenne kids pre and post microdystrophin treatment that I was amazed by - but they weren't sharable yet. Bo just presented them at Needham...
Pancreatic Cancer Trials Yield Only 1‑2 Month Gains
I remember years ago in pancreatic cancer trials you were realistically looking for 1 to 2 months improvement in survival (at best) in pancreatic cancer trials. Bravo $RVMD.👏
Biotech IPOs Open as Hemab Goes Public
Biotech IPO gates are opening. Congrats also to @JMaraganore (Chair) and Benny Sorensen (CEO) of Hemab, and best of luck.
Live CEO Interviews From Raymond James Biotech Symposium
Programming note: On Tuesday of next week I'll be broadcasting @BiotechTV interviews from the Raymond James Biotech Symposium in New York. Current confirmed CEO interviews: $SEPN $AKBA $WVE $VERA $DYN $KRRO (and maybe more). Let me know any questions for...
Biotech IPO Surge Expected; List on NYSE
Getting to know the @NYSE and Johanna and Eric has been a highlight of mine since their earliest support of BiotechTV. I have no doubt we will see a strong IPO pipeline for biotech this year, and I hope you...
Little‑Known Kymera Fact Worth Sharing Today
With Kymera in the news today, reposting this cool little known fact about them that I learned on a prior visit. https://t.co/ctlvveAlJZ